CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX – Get Free Report) was the recipient of a significant drop in short interest in August. As of August 31st, there was short interest totaling 788,894 shares, a drop of 39.0% from the August 15th total of 1,293,928 shares. Based on an average trading volume of 4,573,541 shares, the days-to-cover ratio is currently 0.2 days.
CNBX Pharmaceuticals Price Performance
Shares of CNBX remained flat at $0.00 during trading hours on Friday. The stock had a trading volume of 1,260,105 shares, compared to its average volume of 26,415,012. CNBX Pharmaceuticals has a 12-month low of $0.00 and a 12-month high of $0.00.
About CNBX Pharmaceuticals
CNBX Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the research and development of synthetic cannabinoid-based drug candidates. The company’s proprietary platform applies medicinal chemistry techniques to design novel small-molecule analogs of naturally occurring cannabinoids, aiming to improve efficacy and safety compared with existing therapies. Its pipeline includes multiple preclinical compounds targeting neuropathic and chronic pain, with a goal of advancing these candidates through IND-enabling studies.
Headquartered in Costa Mesa, California, CNBX Pharmaceuticals collaborates with contract research organizations and academic partners to conduct pharmacology and toxicology studies as well as scale up manufacturing processes.
Featured Stories
- Five stocks we like better than CNBX Pharmaceuticals
- These 3 Stocks Are Drawing Insider Buyers for Very Different Reasons
- Braze Beat Expectations—Now 2 SaaS Peers Are in Focus
- 3 Zero-Fee ETFs Worth More Than Their Cost
- 3 Nimble Free Cash Flow Names With Light Assets
Receive News & Ratings for CNBX Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CNBX Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
